Buy Nestle India, target of Rs 1800: IIFL

Published on Fri, Jun 27, 2008 at 12:05 |  Source : Moneycontrol.com

Updated at Fri, Jun 27, 2008 at 12:09  

10914 Investors following Nestle. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

IIFL has recommended a buy rating on Nestle India a one-year target price of Rs 1800 in its June 26, 2008 research report. "Nestlé is one of the best plays on the ongoing boom in India's processed-food industry, given its dominant presence in underpenetrated and high-growth categories such as infant and baby foods, noodles, ketchups and confectioneries. High raw-material prices notwithstanding, we expect Nestlé's earnings growth to accelerate on the back of increased pricing power and strong underlying volume growth, further aided by a decline in tax rates."

"We project an earnings CAGR of 24% over CY07-10ii. We initiate coverage with a Buy rating and a one-year target price of Rs 1800, based on a target multiple of 23x one-year forward earnings, in line with Nestlé's five-year average multiple," says IIFL's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment......

Attachments : tfp20080626.pdf

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com